A carregar...
Biomarker predictors for immunotherapy benefit in breast: beyond PD-L1
PURPOSE OF REVIEW: Immune checkpoint blockade (ICB) has changed the clinical course of multiple cancer types and durable responses have now been observed in breast cancer (BC) patients. Most data suggest that, compared to other subtypes, triple-negative BC (TNBC) patients are more responsive to ICB,...
Na minha lista:
| Publicado no: | Curr Breast Cancer Rep |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7731906/ https://ncbi.nlm.nih.gov/pubmed/33312343 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12609-019-00331-5 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|